2024
Vaccine effectiveness of 3rd generation mpox vaccines against mpox and disease severity: A systematic review and meta-analysis
Pischel L, Martini B, Yu N, Cacesse D, Tracy M, Kharbanda K, Ahmed N, Patel K, Grimshaw A, Malik A, Goshua G, Omer S. Vaccine effectiveness of 3rd generation mpox vaccines against mpox and disease severity: A systematic review and meta-analysis. Vaccine 2024, 42: 126053. PMID: 38906763, DOI: 10.1016/j.vaccine.2024.06.021.Peer-Reviewed Original ResearchPost-exposure prophylaxisMVA-BNVaccine effectivenessMeta-analysisTime of administrationNewcastle-Ottawa ScaleRisk of publication biasMeasuring vaccine efficacyImmortal time biasImmunogenicity studiesNewcastle-OttawaWeb of ScienceVaccine efficacyAnimal studiesEgger's testDisease severityFunnel plotPrimary searchDosePublication biasStudy qualityVaccineSystematic reviewVaccination timingMpox outbreak
2022
Characterization of parental intention to vaccinate elementary school aged children in the state of California
Dudley M, Barnett E, Paulenich A, Omer S, Schuh H, Proveaux T, Buttenheim A, Klein N, Delamater P, McFadden S, Patel K, Salmon D. Characterization of parental intention to vaccinate elementary school aged children in the state of California. Vaccine 2022, 41: 630-635. PMID: 36543683, PMCID: PMC9762501, DOI: 10.1016/j.vaccine.2022.12.030.Peer-Reviewed Original ResearchConceptsCOVID-19 vaccinationCoronavirus disease 2019 (COVID-19) vaccinesCOVID-19 vaccine confidenceSchool-entry mandatesEmergency use authorizationCOVID-19 vaccineUS FDA approvalCOVID-19Vaccine uptakeChildhood vaccinesHesitant parentsVaccine confidenceFDA approvalSociodemographic characteristicsVaccineParental intentionChildrenVaccinationCalifornia parentsPublic healthSchool childrenParental attitudesApprovalParentsUptakeAdenovirus-Based Vaccines and Thrombosis in Pregnancy: A Systematic Review and Meta-analysis
Pischel L, Patel KM, Goshua G, Omer SB. Adenovirus-Based Vaccines and Thrombosis in Pregnancy: A Systematic Review and Meta-analysis. Clinical Infectious Diseases 2022, 75: 1179-1186. PMID: 35134164, PMCID: PMC9383370, DOI: 10.1093/cid/ciac080.Peer-Reviewed Original ResearchConceptsAdenovirus-vectored vaccinePregnant womenVector vaccinesSystematic reviewGeneral populationAdenovirus vector-based vaccinesClinical trial populationsVector-based vaccinesCrucial risk factorVaccine recipientsHypercoagulable stateTrial populationRisk factorsClinical trialsJohnson vaccineRare caseVaccine componentsThrombocytopeniaVaxzevria vaccineMeta-AnalysisVaccine developmentVaccinePotential associationCoagulopathyInfectious diseases